Moreover, supporting the invasive phenotype of CSCs by CD90+ CAFs has been observed following the habitation of CD44+ CD90+ CSCs at periphery sites of breast tumors, where they were in direct contact with CAFs [276]. This evidence concerns the gene THY1 and breast neoplasm.